GRI Bio Inc [NASDAQ: GRI] plunged by -$0.18 during the normal trading session on Wednesday and reaching a high of $1.35 during the day while it closed the day at $1.21.
GRI Bio Inc stock has also loss -38.89% of its value over the past 7 days. However, GRI stock has declined by -40.98% in the 3 months of the year. Over the past six months meanwhile, it has lost -8.33% and lost -90.99% year-on date.
The market cap for GRI stock reached $3.95 million, with 3.27 million shares outstanding and 3.27 million shares in the current float. Compared to the average trading volume of 1.24M shares, GRI reached a trading volume of 6891399 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about GRI Bio Inc [GRI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GRI shares is $23.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GRI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for GRI Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 09, 2024.
The Price to Book ratio for the last quarter was 1.98, with the Price to Cash per share for the same quarter was set at 1.24.
GRI stock trade performance evaluation
GRI Bio Inc [GRI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -38.89. With this latest performance, GRI shares dropped by -30.46% in over the last four-week period, additionally sinking by -8.33% over the last 6 months – not to mention a drop of -91.41% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GRI stock in for the last two-week period is set at 31.62, with the RSI for the last a single of trading hit 0.2329, and the three-weeks RSI is set at 0.2034 for GRI Bio Inc [GRI]. The present Moving Average for the last 50 days of trading for this stock 1.8676, while it was recorded at 1.6300 for the last single week of trading, and 2.2455 for the last 200 days.
GRI Bio Inc (GRI) Capital Structure & Debt Analysis
According to recent financial data for GRI Bio Inc. ( GRI), the Return on Equity (ROE) stands at -397.84%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -219.61%, reflecting the company’s efficiency in generating profits from its assets. Additionally, GRI Bio Inc’s Return on Invested Capital (ROIC) is -650.32%, showcasing its effectiveness in deploying capital for earnings.
GRI Bio Inc (GRI) Efficiency & Liquidity Metrics
Based on GRI Bio Inc’s (GRI) latest financial statements, the Debt-to-Equity Ratio is 0.04%, indicating its reliance on debt financing relative to shareholder equity.
GRI Bio Inc (GRI) Efficiency & Liquidity Metrics
From an operational efficiency perspective, GRI Bio Inc. (GRI) effectively leverages its workforce, generating an average of -$3290000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.70% and a Quick Ratio of 1.70%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for GRI Bio Inc [GRI] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GRI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for GRI Bio Inc go to 80.04%.
GRI Bio Inc [GRI]: Institutional Ownership
There are presently around $4.11%, or 4.11%% of GRI stock, in the hands of institutional investors.
